# Mounjaro vs Zepbound: Dosage, Uses and Side Effects

Source: https://pepvault.app/drugs/compare/mounjaro-vs-zepbound

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Brand-name drugs](https://pepvault.app/drugs) Mounjaro vs Zepbound

Same ingredient, two names · tirzepatide

# Mounjaro vs Zepbound

From the two FDA labels, read Nov 18, 2026 [Published by PepVault](https://pepvault.app/guides/how-we-research)

Mounjaro and Zepbound are the same medicine, tirzepatide, under two names from Eli Lilly.

What differs is the label. FDA approved Mounjaro for blood sugar control in type 2 diabetes from age 10, and lowering heart risk in adults with type 2 diabetes. Zepbound is approved for weight loss and keeping it off, and obstructive sleep apnea in adults with obesity.

## Label against label

Mounjaro and Zepbound, from their FDA labels and Drugs@FDA

| Compared | [Mounjaro](https://pepvault.app/drugs/mounjaro) | [Zepbound](https://pepvault.app/drugs/zepbound) |
| --- | --- | --- |
| Active ingredient | tirzepatide | tirzepatide |
| Class | GIP and GLP-1 receptor agonist | GIP and GLP-1 receptor agonist |
| Maker | Eli Lilly | Eli Lilly |
| Approved for | Type 2 diabetes (adults and children 10 and up); heart risk | Weight reduction; obstructive sleep apnea with obesity |
| Forms | Single-dose pen or vial; Multi-dose vial or KwikPen | Single-dose pen or vial; Multi-dose vial or KwikPen |
| How often | once a week | once a week |
| Starting dose | 2.5 mg a week | 2.5 mg a week |
| Top dose on the label | 15 mg a week | 15 mg a week |
| Most reported side effect | Nausea, 18% on 15 mg (placebo 4%) | Nausea, 28% on 15 mg (placebo 8%) |
| Boxed warning | “RISK OF THYROID C-CELL TUMORS” | “RISK OF THYROID C-CELL TUMORS” |
| First approved | 2022 | 2023 |

Each label’s side-effect figure comes from its own trials, at its own doses and in its own patients; as the labels themselves say, rates from different trials can’t be compared directly.

## The two dosing schedules

This is the dosing schedule as the FDA label states it. A prescriber sets the actual dose and when it changes; it is not an instruction to the reader.

### Mounjaro, once a week

Mounjaro’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.

### Zepbound, once a week

Zepbound’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-vs-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## A missed dose, on each label

- [Mounjaro](https://pepvault.app/drugs/mounjaro): A missed Mounjaro dose can still be given within 4 days (96 hours). After that it is skipped and the next one comes on the usual day.
- [Zepbound](https://pepvault.app/drugs/zepbound): Zepbound’s missed-dose rule gives 4 days (96 hours): within that window the dose is taken as soon as possible; after it, the dose is skipped and the week carries on as usual.

## The research on the ingredient

- [Tirzepatide in the peptide library: the research on the one ingredient](https://pepvault.app/peptides/tirzepatide)
- [Mounjaro: the label in full](https://pepvault.app/drugs/mounjaro)
- [Zepbound: the label in full](https://pepvault.app/drugs/zepbound)

## Questions

### Are Mounjaro and Zepbound the same drug?

They hold the same active ingredient, tirzepatide, from Eli Lilly. They are approved for different uses and come in different forms and doses.

### What are Mounjaro and Zepbound approved for?

Mounjaro is approved for blood sugar control in type 2 diabetes from age 10, and lowering heart risk in adults with type 2 diabetes. Zepbound is approved for weight loss and keeping it off, and obstructive sleep apnea in adults with obesity.

### How often are Mounjaro and Zepbound taken?

Mounjaro is taken once a week, as an injection; Zepbound once a week, as an injection.

### What are the dose ranges of Mounjaro and Zepbound?

On their labels, Mounjaro runs 2.5 mg to 15 mg once a week, and Zepbound 2.5 mg to 15 mg once a week. A prescriber sets the actual dose.

### What is the most common side effect of Mounjaro and Zepbound?

On Mounjaro’s label: nausea, 18% on 15 mg (placebo 4%). On Zepbound’s: nausea, 28% on 15 mg (placebo 8%).

## Sources

- [MOUNJARO (tirzepatide) injection, for subcutaneous use, FDA label on DailyMed](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0) (version 40, published Sep 2, 2026; read Nov 18, 2026)
- [ZEPBOUND (tirzepatide) injection, for subcutaneous use, FDA label on DailyMed](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b) (version 40, published Sep 2, 2026; read Nov 18, 2026)
- [Drugs@FDA, NDA 215866](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215866) (Mounjaro, the injection; application first approved 2022)
- [Drugs@FDA, NDA 217806](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217806) (Zepbound, the injection; application first approved 2023)

PepVault is not affiliated with Eli Lilly. Mounjaro is a trademark of its owner. Zepbound is a trademark of its owner.

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-vs-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-vs-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## On the two labels

### Read further

- [Tirzepatide in the peptide library: the research on the one ingredient](https://pepvault.app/peptides/tirzepatide)
- [Mounjaro: the label in full](https://pepvault.app/drugs/mounjaro)
- [Zepbound: the label in full](https://pepvault.app/drugs/zepbound)

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-vs-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Brand-name drugs

- [Every brand, by ingredient](https://pepvault.app/drugs)
- [Mounjaro](https://pepvault.app/drugs/mounjaro)
- [Zepbound](https://pepvault.app/drugs/zepbound)

## More pairs

- [Ozempic vs Mounjaro](https://pepvault.app/drugs/compare/ozempic-vs-mounjaro)
- [Wegovy vs Mounjaro](https://pepvault.app/drugs/compare/wegovy-vs-mounjaro)
- [Wegovy vs Zepbound](https://pepvault.app/drugs/compare/wegovy-vs-zepbound)
- [Ozempic vs Zepbound](https://pepvault.app/drugs/compare/ozempic-vs-zepbound)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it. PepVault is not affiliated with Eli Lilly. Mounjaro is a trademark of its owner. Zepbound is a trademark of its owner.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
